Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Brazelton

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Opinion in Immunology|October 1, 1996
Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomideT R Brazelton, R E Morris
Cell|July 6, 2001
The evolving concept of a stem cell: entity or function?H M Blau, T R Brazelton, J M Weimann
The Journal of Clinical Investigation|June 8, 2001
Not the usual suspects: the unexpected sources of tissue regenerationM L Springer, T R Brazelton, H M Blau
Transplantation Proceedings|September 18, 1997
Infiltrating recipient mesenchymal cells form the obliterative airway disease lesion and dramatically remodel graft tissue in a model of chronic lung rejectionT R Brazelton, R Shorthouse, X Huang, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 10, 2000
Chronic rejection: the result of uncontrolled remodelling of graft tissue by recipient mesenchymal cells? Data from two rodent models and the effects of immunosuppressive therapiesT R Brazelton, B Adams, R Shorthouse, et al.
Transplantation|July 4, 2001
Prolonged inhibition of obliterative airway disease in murine tracheal allografts by brief treatment with anti-leukocyte function-associated antigen-1 (CD11a) monoclonal antibodyM Morikawa, T R Brazelton, G J Berry, et al.
Transplantation Proceedings|September 18, 1997
Progression of obliterative airway disease occurs despite the removal of immune reactivity by retransplantationT R Brazelton, B A Adams, A C Cheung, et al.
Science (New York, N.Y.)|December 2, 2000
From marrow to brain: expression of neuronal phenotypes in adult miceT R Brazelton, F M Rossi, G I Keshet, et al.
Transplantation|October 3, 2000
Epithelial re-growth is associated with inhibition of obliterative airway disease in orthotopic tracheal allografts in non-immunosuppressed ratsT S Ikonen, T R Brazelton, G J Berry, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|January 19, 1999
Development of a high-performance liquid chromatographic-electrospray mass spectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycinI Segarra, T R Brazelton, N Guterman, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Immunology|October 1, 1996
Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomideT R Brazelton, R E Morris
Cell|July 6, 2001
The evolving concept of a stem cell: entity or function?H M Blau, T R Brazelton, J M Weimann
The Journal of Clinical Investigation|June 8, 2001
Not the usual suspects: the unexpected sources of tissue regenerationM L Springer, T R Brazelton, H M Blau
Transplantation Proceedings|September 18, 1997
Infiltrating recipient mesenchymal cells form the obliterative airway disease lesion and dramatically remodel graft tissue in a model of chronic lung rejectionT R Brazelton, R Shorthouse, X Huang, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 10, 2000
Chronic rejection: the result of uncontrolled remodelling of graft tissue by recipient mesenchymal cells? Data from two rodent models and the effects of immunosuppressive therapiesT R Brazelton, B Adams, R Shorthouse, et al.
Transplantation|July 4, 2001
Prolonged inhibition of obliterative airway disease in murine tracheal allografts by brief treatment with anti-leukocyte function-associated antigen-1 (CD11a) monoclonal antibodyM Morikawa, T R Brazelton, G J Berry, et al.
Transplantation Proceedings|September 18, 1997
Progression of obliterative airway disease occurs despite the removal of immune reactivity by retransplantationT R Brazelton, B A Adams, A C Cheung, et al.
Science (New York, N.Y.)|December 2, 2000
From marrow to brain: expression of neuronal phenotypes in adult miceT R Brazelton, F M Rossi, G I Keshet, et al.
Transplantation|October 3, 2000
Epithelial re-growth is associated with inhibition of obliterative airway disease in orthotopic tracheal allografts in non-immunosuppressed ratsT S Ikonen, T R Brazelton, G J Berry, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|January 19, 1999
Development of a high-performance liquid chromatographic-electrospray mass spectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycinI Segarra, T R Brazelton, N Guterman, et al.
Pageof 2